The accumulation of chronic active lesions may represent one of the contributors to clinical disability independent of clinical relapses and overt inflammatory MRI activity (i.e., PIRA) [61]
Research and Development BPC-157 was originally developed over 20 years ago as an anti-ulcer agent due to its marked cytoprotective benefits
Karabasz, A., Lachowicz, D., Karewicz, A., Mezyk-Kopec, R., Staliska, K., Werner, E., Cierniak, A., Dyduch, G., Bereta, J., Bzowska, M., 2019
Spec.: 10 U Description: Constitutive rat brain NOS isoform
Glenmark's Green House Gas (GHG) emission reduction targets have been approved in 2023 by the Science Based Target initiative (SBTi), making it only the second pharmaceutical company in India to achieve this